Ponce Health Sciences University

The Inner Circle Acknowledges, Joshua T. Billingsley, MD, MS, FAANS, as a Pinnacle Life Member for his contributions to the field of Neurological Surgery

Retrieved on: 
星期三, 十一月 29, 2023
Inner circle, Glioma, Brain, Advocate Lutheran General Hospital, Rush University, Advocate Christ Medical Center, Disorder, Head, Neurosurgery, Tetraplegia, Advocate Good Samaritan Hospital, Spine, Hospital, Physician, Patient, Nervous system, Infection, Science, University, Movement, Neoplasm, Rehabilitation, Mentorship, Ponce Health Sciences University, Diagnosis, Memory, Education, Congress, Public, Family, ABNS, Stroke, Empathy, Spinal cord, Master, Idaho State University, Accessory nerve disorder, Sympathetic nervous system, Nursing, Dentistry, Endocrinology, Chemistry, Virology, MD, Microbiology

GLENVIEW, Ill., Nov. 29, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joshua T. Billingsley, MD, MS, FAANS, is acknowledged as a Pinnacle Life Member for his contributions to the field of Neurological Surgery.

Key Points: 
  • GLENVIEW, Ill., Nov. 29, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Joshua T. Billingsley, MD, MS, FAANS, is acknowledged as a Pinnacle Life Member for his contributions to the field of Neurological Surgery.
  • Neurosurgeons are doctors who diagnose and treat problems with the nervous system, often by performing surgery on the brain or spine.
  • They treat strokes, tumors, cervical and lumbar disc disease, infections, and head or spinal cord injuries.
  • Aside from his professional pursuits, the doctor enjoys cycling; woodworking; and ocean fishing.

Face Expert Dr. Natalia Vidal Laureano Joins Exclusive Haute Beauty Network

Retrieved on: 
星期四, 十一月 16, 2023
Coral Gables, Florida, Ponce Health Sciences University, American Board of Surgery, Love, Surgeon, Burn, General surgery, Elective surgery, Plastic surgery, University, Rhinoplasty, Quality of life, Beauty, Face, Life, University of Miami, Dentistry, Biology

NEW YORK, Nov. 16, 2023 /PRNewswire-PRWeb/ -- Dr. Natalia Vidal Laureano believes in the motto: "You have one life, quality of life matters." She is a double-board certified plastic surgeon. She is certified by the American Board of Surgery and by the American Board of Plastic Surgery. She specializes in aesthetic procedures of the face and body including body contouring, breast procedures, labiaplasty, and rhinoplasty. Her goal is to improve the quality of life by boosting the patient's self-esteem and confidence level.

Key Points: 
  • Dr. Natalia Vidal Laureano joins Haute Beauty Network as a face expert representing the Coral Gables, FL market.
  • NEW YORK, Nov. 16, 2023 /PRNewswire-PRWeb/ -- Dr. Natalia Vidal Laureano believes in the motto: "You have one life, quality of life matters."
  • She specializes in aesthetic procedures of the face and body including body contouring, breast procedures, labiaplasty, and rhinoplasty.
  • Learn more about Dr. Natalia Vidal Laureano by visiting: https://hauteliving.com/hautebeauty/member/dr-natalia-vidal-laureano/

JAMA Publishes Geneoscopy’s Pivotal CRC-PREVENT Trial Results, Reporting Highest Sensitivity for Detecting Colorectal Cancer and Advanced Adenomas Among Available Noninvasive Screening Tests

Retrieved on: 
星期一, 十月 23, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Medical Devices, GI, FDA, American College, AA, Incidence, Multi, JD, RNA, Oregon Health & Science University, ACG, American Medical Association, Colorectal cancer, Medicine, Doctor of Philosophy, MBA, PMA, American College of Gastroenterology, Journal, Inflammatory bowel disease, CRC, AAS, IBD, USPSTF, Cancer, Ponce Health Sciences University, Patient, Gastrointestinal disease, Pharmaceutical industry, Vaccine, MD

The novel study will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting in Vancouver, Canada, October 20-25, showcasing its highly sensitive screening test for colorectal cancer (CRC) and advanced adenomas (AA).

Key Points: 
  • The novel study will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting in Vancouver, Canada, October 20-25, showcasing its highly sensitive screening test for colorectal cancer (CRC) and advanced adenomas (AA).
  • “Geneoscopy is dedicated to addressing this challenge and improving access to a reliable, noninvasive CRC screening test, especially as incidence is rising among younger populations.
  • Notably, for younger participants (ages 45 to 49), CRC sensitivity was 100% and AA sensitivity was 45%.
  • There is a notable gap in data regarding the efficacy of noninvasive screening tests for this age group, including the sensitivity for colorectal cancer (CRC) and advanced adenomas,” said Dr. Lieberman.

WITH AFFIRMATIVE ACTION OUT, LANDMARK STUDY PROVIDES NEW APPROACH TO DIVERSIFYING THE PHYSICIAN WORKFORCE

Retrieved on: 
星期三, 十月 18, 2023
THI, MSMS, Association of American Medical Colleges, Science, Physician, MD, Workforce, USMLE, Research, Master of Science, MCAT, ST, Curriculum, AAMC, PHSU, University, Student, Ponce Health Sciences University, Nursing, Management, Medicine

ST. LOUIS, Oct. 18, 2023 /PRNewswire/ -- Ponce Health Sciences University (PHSU) and Tiber Health Innovation (THI) announce the publication of a report in Academic Medicine, the flagship journal of the Association of American Medical Colleges (AAMC), titled "Increasing Diversity in the Physician Workforce: Pathway Programs and Predictive Analytics."

Key Points: 
  • Two groups were compared: students who were directly admitted to PHSU MD versus students who went through MSMS before PHSU MD.
  • "MD admissions committees that rely on the MCAT can upgrade their evaluation process by implementing this data-driven, performance-based approach.
  • PHSU/THI's goal is to expand this approach across the U.S. by partnering with universities that want to offer the MSMS program to their own students.
  • PHSU/THI are seeking more universities to join the MSMS University Network and help address the lack of diversity in the physician workforce.

CorePlus Shows Success With Real-World Utilization of Ibex's AI Platform for Routine Cancer Diagnosis, Supporting Improved Patient Outcomes

Retrieved on: 
星期二, 十月 10, 2023
Diagnosis, Triage, Professor, FACS, Hospital, Breast, AI, MD, Urology, Prostate, Marie Cassidy, Cancer, Ponce Health Sciences University, Laboratory, Entrepreneurship, Department of Urology, University of Virginia, Pathology, Prostate cancer, Malignancy, Patient, Medical device, Medical imaging, Ibex

BOSTON and CAROLINA, Puerto Rico, Oct. 10, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, and CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high complexity CLIA-certified clinical and anatomic pathology laboratory, today announced CorePlus has diagnosed over 10,000 cases using Galen™, Ibex's AI-powered cancer diagnostics platform. In a significant boost to patient outcomes, pathologists used AI-driven insights from Galen to correct the diagnosis of over 150 patients.

Key Points: 
  • In a significant boost to patient outcomes, pathologists used AI-driven insights from Galen to correct the diagnosis of over 150 patients.
  • Galen demonstrated outstanding outcomes across multiple clinical studies performed on various tissue types and diagnostic workflows1,2,3,4,5.
  • "I am delighted to see CorePlus leading the way in adoption, demonstrating how patient outcomes can be improved through the implementation of AI for primary diagnosis.
  • We remain focused on bringing our AI platform to labs around the world to help pathologists reach zero misdiagnoses in cancer, and CorePlus demonstrates how this is achievable."

AHN Opens New Precision Medicine and Developmental Therapeutics Cancer Clinic at AGH

Retrieved on: 
星期四, 九月 7, 2023
Allegheny, Telehealth, University, Cancer Institute, American Board of Internal Medicine, Personalized medicine, Cancer, Development of the human body, Multimedia, Allegheny General Hospital, MS, American Board of Commissioners for Foreign Missions, Oregon Health Plan, Allegheny Health Network, National Cancer Center, Protein, Medical director, AHN, Patient, Physician, Walter Reed National Military Medical Center, Internal medicine, Medicine, Ponce Health Sciences University, Oncology, FDA, Health, Empowerment, Knight Cancer Institute, Disease, Hospital, Pharmaceutical industry, Medical imaging, MD

PITTSBURGH, Sept. 7, 2023 /PRNewswire-PRWeb/ -- The Allegheny Health Network Cancer Institute (AHNCI) announced today that it has established one of the region's first clinics dedicated to precision cancer medicine and has appointed nationally recognized medical oncologist Ariel Lopez-Chavez, MD, MS, to serve as director of the new clinic.

Key Points: 
  • The AHNCI's Precision Medicine and Developmental Therapeutics Clinic focuses on serving adults with metastatic solid tumors, and patients who may need second opinions or are seeking novel treatment options for rare, complex, or advanced-stage cancers.
  • The clinic is based at the AHN Cancer Institute at Allegheny General Hospital in Pittsburgh's North Side and offers both in-person and telemedicine appointments to patients.
  • Because every cancer patient has unique characteristics and preferences, a unique genetic profile, and because cancer is a dynamic, heterogeneous disease, precision therapies are considered the next frontier of cancer treatment.
  • As director of the Precision Medicine and Developmental Therapeutics Clinic, Dr. Lopez-Chavez will lead an innovative program that offers cancer patients access to clinical research trials and novel technologies aimed at maximizing cancer recovery and improving their overall well-being.

One Mind Announces the 2023 Rising Star Awards Funding Innovative Research in Mental Health

Retrieved on: 
星期二, 八月 15, 2023
Neurology, Health, Mental Health, Columbia University, Columbia University Irving Medical Center, Depression, Oregon Health & Science University, Therapy, Tic disorder, DPI, Schizophrenia, Disability, DSM-IV codes, Rising Star, Deyo, Research, Multimedia, Risk, Suicide, Brain, History, Doctor of Philosophy, Person, Mount Sinai, Vollum Institute, Assistant professor, Neurosurgery, Post-traumatic stress disorder, ACeS, Icahn School of Medicine at Mount Sinai, Eating, Ponce Health Sciences University, Mental health, Psychiatry, Anxiety, Bipolar disorder, Pharmaceutical industry, Nursing, Saunders

One Mind™, a leading mental health non-profit, has announced the three recipients of the 2023 One Mind Rising Star Awards.

Key Points: 
  • One Mind™, a leading mental health non-profit, has announced the three recipients of the 2023 One Mind Rising Star Awards.
  • View the full release here: https://www.businesswire.com/news/home/20230815929713/en/
    The One Mind Rising Star Awards supports early-career investigators in neuroscience, psychiatry, and related disciplines who pursue research to advance the understanding, treatment, and prevention of mental illness.
  • “We are excited to continue transforming the world’s mental health by supporting this new cohort of the 2023 One Mind Rising Stars,” states One Mind President Brandon Staglin.
  • The 2023 Rising Stars will present their research at a special Science & Innovation Symposium organized during the 29th One Mind Music Festival for Brain Health.

AMERICAN SKIN ASSOCIATION ANNOUNCES 2023 RESEARCH ACHIEVEMENT AWARDS

Retrieved on: 
星期三, 五月 17, 2023
ASA, AWARD, Oregon Health and Science University Center for Women's Health, ISID, Skin cancer, Public policy, Atopic dermatitis, Research, Keio University, Inflammation, Doctor of Philosophy, Autoimmunity, Homeostasis, Peripheral tolerance, Psoriasis, Oregon Health & Science University, Professor, Pemphigus, International Society for Bipolar Disorders, Melanoma, Allergy, GEORGE, Ponce Health Sciences University, Vitiligo, Skin, Medical device, Dermatology, MD

NEW YORK, May 17, 2023 /PRNewswire/ -- American Skin Association (ASA) announced the recipients of the 2023 David Martin Carter Mentor Award, 2023 George W. Hambrick Award, and the 2023 Research Achievement Awards at the International Societies for Investigative Dermatology (ISID) in Tokyo, Japan.

Key Points: 
  • MASAYUKI AMAGAI, MD, PhD 2023 RECIPIENT OF GEORGE W. HAMBRICK AWARD
    NEW YORK, May 17, 2023 /PRNewswire/ -- American Skin Association (ASA) announced the recipients of the 2023 David Martin Carter Mentor Award, 2023 George W. Hambrick Award, and the 2023 Research Achievement Awards at the International Societies for Investigative Dermatology (ISID) in Tokyo, Japan.
  • "ASA is honored to recognize Dr. Hanifin and Dr. Amagai and all the 2023 Research Achievement Award recipients for their tireless efforts in the field of dermatology.
  • Dr. Amagai's clinical and research interests center on autoimmune and allergic skin diseases, skin barrier, and skin immunology.
  • ASA's Research Achievement Awards were instituted in 1989 to help identify established scientists in investigative dermatology and cutaneous biology.

NUTEX HEALTH ANNOUNCES CHANGE TO ITS BOARD OF DIRECTORS

Retrieved on: 
星期三, 四月 5, 2023
Disaster medicine, Emergency medicine, University, Emergency, Law enforcement, American Board of Emergency Medicine, MBA, International Union of Physiological Sciences, Ponce Health Sciences University, Nutex Health, EMS, Weill Cornell Medicine, American Board of Commissioners for Foreign Missions, Medical director, NewYork-Presbyterian Queens, Patient, Physician, Hospital, Fellow of the American College of Emergency Physicians, American College, Phoenix, Medical degree, Pager (company), Level 1, Nursing

from the Company's Board of Directors at the end of his one year term commitment and the election of Danniel Stites, M.D.

Key Points: 
  • from the Company's Board of Directors at the end of his one year term commitment and the election of Danniel Stites, M.D.
  • Dr. Stites is board certified in Emergency Medicine by the American Board of Emergency Medicine and is a Fellow of the American College of Emergency Physicians.
  • We are also pleased to welcome Dr. Stites to the Nutex Board.
  • "I am delighted to be joining the Board at Nutex Health.

University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers

Retrieved on: 
星期一, 三月 6, 2023
Oncology, Health, Technology, Genetics, Software, Biotechnology, Bone marrow, Sophia Genetics, GENETICS, Artificial intelligence, Tumors of the hematopoietic and lymphoid tissues, Leukemia, Hematology, Medicine, Sophia, Patient, Multiple myeloma, UAMS, University of Arkansas for Medical Sciences, University, Lymphoma, NGS, Ponce Health Sciences University, Pharmaceutical industry, Medical imaging

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, today announced the University of Arkansas for Medical Sciences (UAMS), based in Little Rock, AR, will use SOPHiA GENETICS’ platform to support their clinical oncology research.

Key Points: 
  • SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, today announced the University of Arkansas for Medical Sciences (UAMS), based in Little Rock, AR, will use SOPHiA GENETICS’ platform to support their clinical oncology research.
  • As the only health sciences university in the state of Arkansas and the state’s largest public employer, UAMS is a cornerstone of medical research and treatment for the state.
  • “Our mission at SOPHiA GENETICS is to democratize data-driven medicine, making it more accessible to all,” said Ken Freedman, Chief Revenue Officer, SOPHiA GENETICS.
  • The SOPHiA DDM™ for Blood Cancers solution will put increased data at the fingertips of clinical researchers.”
    For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM , or connect on Twitter , LinkedIn , Facebook , and Instagram .